EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,120,000 | -2.8% | 98,500 | 0.0% | 0.47% | -3.9% |
| Q1 2018 | $2,182,000 | -27.1% | 98,500 | 0.0% | 0.48% | -26.8% |
| Q4 2017 | $2,994,000 | +25.4% | 98,500 | 0.0% | 0.66% | +18.2% |
| Q3 2017 | $2,387,000 | -1.6% | 98,500 | 0.0% | 0.56% | -8.2% |
| Q2 2017 | $2,426,000 | +76.6% | 98,500 | +55.4% | 0.61% | +55.9% |
| Q1 2017 | $1,374,000 | +45.4% | 63,400 | 0.0% | 0.39% | +18.4% |
| Q4 2016 | $945,000 | +128.3% | 63,400 | +95.7% | 0.33% | +120.7% |
| Q3 2016 | $414,000 | – | 32,400 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |